Overview

Freenome Holdings, Inc. is a biotechnology company focused on developing and deploying early detection blood tests for cancer through the use of machine learning and advanced multiomics. The company's mission is to enable proactive treatment and better outcomes by detecting cancer at an early and manageable stage.

Therapeutic areas

OncologyDiagnostics

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to Freenome Holdings, Inc. in our records. Events are linked by company name and identifier, so this is not proof that none exist; check the FDA's own databases before relying on it.

For suppliers

Is this Freenome Holdings, Inc.?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.